Published in CA Cancer J Clin on December 05, 2014
American Cancer Society Colorectal Cancer Survivorship Care Guidelines. CA Cancer J Clin (2015) 0.86
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on? Nat Rev Clin Oncol (2015) 0.83
Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer Survivors. PLoS One (2016) 0.81
Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer. Psychooncology (2015) 0.77
Neurocognitive functioning and genetic variation in patients with primary brain tumours. Lancet Oncol (2016) 0.77
Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study. Soc Sci Med (2016) 0.76
Effects of Exercise Interventions and Physical Activity Behavior on Cancer Related Cognitive Impairments: A Systematic Review. Biomed Res Int (2016) 0.76
Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients. Curr Opin Support Palliat Care (2016) 0.75
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. Breast Cancer (Dove Med Press) (2017) 0.75
Neurocognitive Impairment as One Facet of Cancer-Related Sickness Behavior Symptoms. J Natl Cancer Inst (2015) 0.75
Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer. Cancer Med (2017) 0.75
Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model. Oncotarget (2016) 0.75
Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress. Br J Cancer (2016) 0.75
Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors. Sci Rep (2017) 0.75
TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin. Aging (Albany NY) (2016) 0.75
Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin. ACS Chem Neurosci (2016) 0.75
Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient's assessment of own functioning inventory. Support Care Cancer (2016) 0.75
Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression. Medicine (Baltimore) (2017) 0.75
Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS One (2017) 0.75
Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment. Brain Behav (2017) 0.75
Web-based cognitive training for breast cancer survivors with cognitive complaints-a randomized controlled trial. Psychooncology (2016) 0.75
Cognitive behavioral therapy for cancer-related cognitive dysfunction. Curr Opin Support Palliat Care (2016) 0.75
Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study. Neuropsychiatr Dis Treat (2017) 0.75
Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults. Am J Geriatr Psychiatry (2017) 0.75
Abnormal Development of Dendrites in Adult-Born Rat Hippocampal Granule Cells Induced by Cyclophosphamide. Front Cell Neurosci (2017) 0.75
What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. Br J Haematol (2016) 0.75
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Cognitive reserve. Neuropsychologia (2009) 8.41
The human connectome: a complex network. Ann N Y Acad Sci (2011) 4.07
Video game training enhances cognitive control in older adults. Nature (2013) 3.89
Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol (2011) 3.69
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst (1998) 3.67
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer (2004) 3.50
Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease. Neuroimage (2011) 3.47
Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol (2002) 3.13
Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer (2007) 3.12
Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci U S A (2000) 2.99
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer (2010) 2.88
Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev (2012) 2.82
Theoretical, statistical, and practical perspectives on pattern-based classification approaches to the analysis of functional neuroimaging data. J Cogn Neurosci (2007) 2.78
Neuroanatomical substrates of age-related cognitive decline. Psychol Bull (2011) 2.75
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol (2014) 2.55
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol (2010) 2.52
Executive functions and self-regulation. Trends Cogn Sci (2012) 2.50
Exercise, cognition, and the aging brain. J Appl Physiol (1985) (2006) 2.48
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer (2007) 2.43
Employment pathways in a large cohort of adult cancer survivors. Cancer (2005) 2.38
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol (2006) 2.34
Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol (2004) 2.24
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat (2006) 2.17
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat (2008) 2.16
The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst (2002) 2.14
Executive functions and their disorders. Br Med Bull (2003) 2.07
Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology (2006) 2.06
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol (2011) 2.06
Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncol (2008) 2.01
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer (2006) 2.00
'Chemobrain' in breast carcinoma?: a prologue. Cancer (2004) 1.98
Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst (2014) 1.96
Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat (2007) 1.95
Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol (2007) 1.94
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat (2010) 1.89
Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry (2009) 1.89
Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst (2013) 1.86
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp (2010) 1.83
Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv (2009) 1.81
Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc (2011) 1.79
Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci (2013) 1.79
Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol (2006) 1.75
Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol (2010) 1.75
Real-time fMRI neurofeedback: progress and challenges. Neuroimage (2013) 1.71
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol (2008) 1.71
Improvement of cognitive function by mental and/or individualized aerobic training in healthy elderly subjects. Int J Sports Med (2002) 1.70
Additive effects of physical exercise and environmental enrichment on adult hippocampal neurogenesis in mice. Front Neurosci (2009) 1.70
The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat (2009) 1.66
The role of individual differences in cognitive training and transfer. Mem Cognit (2014) 1.64
Retracted Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling. J Neuroinflammation (2014) 1.63
Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer (2007) 1.62
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am J Neuroradiol (1998) 1.59
Effect of exercise on cognitive performance in community-dwelling older adults: review of intervention trials and recommendations for public health practice and research. J Am Geriatr Soc (2011) 1.57
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc (2006) 1.57
Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst (2006) 1.56
Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage (2004) 1.54
Beneficial effects of physical exercise on neuroplasticity and cognition. Neurosci Biobehav Rev (2013) 1.50
Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol (2012) 1.49
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun (2012) 1.48
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology (2004) 1.48
Symptom management of affective and cognitive disturbance with a group of cancer survivors. Arch Psychiatr Nurs (2010) 1.45
Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer (2005) 1.44
Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol (2012) 1.43
Prevalence and predictors of “subjective cognitive complaints” in the Sydney Memory and Ageing Study. Am J Geriatr Psychiatry (2010) 1.41
Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology (2007) 1.41
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp (2011) 1.40
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun (2012) 1.40
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer (2010) 1.40
Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol (2011) 1.39
Self-regulatory processes and exercise adherence in older adults: executive function and self-efficacy effects. Am J Prev Med (2011) 1.37
Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol (2002) 1.37
Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev (2010) 1.33
Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology (2005) 1.33
The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. Breast (2005) 1.32
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology (2010) 1.32
Executive function moderates the intention-behavior link for physical activity and dietary behavior. Psychol Health (2008) 1.32
Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp (2011) 1.31
Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol (2009) 1.30
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Neurocognitive changes in cancer survivors. Cancer J (2008) 1.27
Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun (2012) 1.27
Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg (2011) 1.27
Why and how physical activity promotes experience-induced brain plasticity. Front Neurosci (2010) 1.25
Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neuroimage Clin (2013) 1.25
Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS). Neuroimage (2013) 1.25
Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep (2012) 1.23
A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults. PLoS One (2013) 1.23
Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Med (1974) 1.20
Altered small-world properties of gray matter networks in breast cancer. BMC Neurol (2012) 1.19
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology (2012) 1.19
Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support Care Cancer (2011) 1.19
Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum (2012) 1.18
Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer (2002) 1.17
Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metab Brain Dis (2008) 1.16
Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer (2013) 1.16
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat (2011) 1.16
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res (2011) 1.16
Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv (2008) 1.16
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol (2011) 2.06
Prematurely born children demonstrate white matter microstructural differences at 12 years of age, relative to term control subjects: an investigation of group and gender effects. Pediatrics (2008) 1.86
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp (2010) 1.83
Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol (2010) 1.75
Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res (2007) 1.48
Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol (2012) 1.43
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp (2011) 1.40
Sex differences in cerebral volumes of 8-year-olds born preterm. J Pediatr (2004) 1.38
GAT: a graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networks. PLoS One (2012) 1.31
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Gender differences in the mesocorticolimbic system during computer game-play. J Psychiatr Res (2008) 1.25
Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep (2012) 1.23
Altered small-world properties of gray matter networks in breast cancer. BMC Neurol (2012) 1.19
Alterations in functional connectivity for language in prematurely born adolescents. Brain (2009) 1.18
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol (2009) 1.17
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat (2011) 1.16
Brain development in Turner syndrome: a magnetic resonance imaging study. Psychiatry Res (2002) 1.14
The brain basis of the phonological deficit in dyslexia is independent of IQ. Psychol Sci (2011) 1.10
Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res (2009) 1.08
Anomalous gray matter structural networks in major depressive disorder. Biol Psychiatry (2013) 1.06
Selective alterations of white matter associated with visuospatial and sensorimotor dysfunction in turner syndrome. J Neurosci (2006) 1.04
A volumetric study of parietal lobe subregions in Turner syndrome. Dev Med Child Neurol (2004) 0.99
Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia. Crit Rev Oncol Hematol (2013) 0.96
Topological properties of large-scale structural brain networks in children with familial risk for reading difficulties. Neuroimage (2013) 0.94
Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment? Life Sci (2013) 0.94
Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res (2009) 0.93
Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging Behav (2015) 0.91
Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer (2008) 0.91
Psychosocial predictors of treatment response to cognitive-behavior therapy for late-life depression: an exploratory study. Aging Ment Health (2013) 0.91
Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat (2005) 0.90
Comparing connectivity pattern and small-world organization between structural correlation and resting-state networks in healthy adults. Neuroimage (2013) 0.90
Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Hum Brain Mapp (2012) 0.89
ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clin Neurophysiol (2008) 0.88
Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Menopause (2015) 0.87
Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Res Bull (2009) 0.86
Influence of choice of null network on small-world parameters of structural correlation networks. PLoS One (2013) 0.85
Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect? J Clin Oncol (2006) 0.85
Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. Clin Breast Cancer (2006) 0.82
Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy. Eur J Cancer (2011) 0.81
Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psychooncology (2013) 0.81
Functional MRI studies in non-CNS cancers. Brain Imaging Behav (2013) 0.80
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psychooncology (2010) 0.76
Cancer-related cognitive impairment and patients' ability to work: a current perspective. Curr Opin Support Palliat Care (2016) 0.75
Health Promotion, Functional Abilities, and Quality of Life Before and During COVID-19 in People With Multiple Sclerosis. Nurs Res (1) 0.75